Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Intangibles (2021 - 2025)

AC Immune has reported Intangibles over the past 5 years, most recently at $63.1 million for Q4 2025.

  • Quarterly Intangibles rose 9.61% to $63.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $63.1 million through Dec 2025, up 9.61% year-over-year, with the annual reading at $63.1 million for FY2025, 9.61% up from the prior year.
  • Intangibles was $63.1 million for Q4 2025 at AC Immune, roughly flat from $63.0 million in the prior quarter.
  • Over five years, Intangibles peaked at $56.8 billion in Q4 2023 and troughed at $52.2 million in Q3 2022.
  • The 5-year median for Intangibles is $57.1 million (2023), against an average of $6.6 billion.
  • Year-over-year, Intangibles plummeted 99.9% in 2022 and then skyrocketed 108506.04% in 2023.
  • A 5-year view of Intangibles shows it stood at $54.7 billion in 2021, then plummeted by 99.9% to $52.3 million in 2022, then skyrocketed by 108506.04% to $56.8 billion in 2023, then plummeted by 99.9% to $57.6 million in 2024, then rose by 9.61% to $63.1 million in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Intangibles are $63.1 million (Q4 2025), $63.0 million (Q3 2025), and $60.9 million (Q2 2025).